Patent · US Active

Compounds, pharmaceutical compositions and uses thereof

US8822471B2 · kind B2 · utility

2Cited by

1References

6Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Bernd Nosse · Biberach an der Riß, DE
Andreas Blum · Darmstadt, DE
Steffen Breitfelder · Aßmannshardt, DE
Armin Heckel · Biberach an der Riß, DE
Frank Himmelsbach · Mittelbiberach, DE
Elke Langkopf · Biberach an der Riß, DE
Bernd Wellenzohn · Friedrichshafen, DE
Neil Ashweek · San Diego, US
Nicole Harriott · San Diego, US

Key dates

Filing date	Mar 13, 2012
Grant date	Sep 2, 2014
Priority date	—
Expiry date	Mar 13, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of general formula I,wherein the groups R1, LP, LQ, Ar, m and n are as defined in the application, which have valuable pharmacological properties, and in particular bind to the GPR119 receptor and modulate its activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.